Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Laurus Labs Ltd. ( (IN:LAURUSLABS) ) has issued an announcement.
Laurus Labs Ltd. held its 20th Annual General Meeting (AGM) on June 26, 2025, via video conferencing. The meeting was attended by key directors and stakeholders, including the Executive Director and CEO, Dr. Chava Satyanarayana, and other board members. A total of 109 participants, representing over 152 million shares, joined the meeting. The AGM proceedings are part of the company’s compliance with SEBI regulations, ensuring transparency and engagement with shareholders.
More about Laurus Labs Ltd.
Laurus Labs Ltd. operates in the pharmaceutical industry, focusing on the development and manufacture of active pharmaceutical ingredients (APIs), formulations, and biotechnology products. The company is committed to providing high-quality pharmaceutical solutions and has a significant presence in the global market.
Average Trading Volume: 77,609
Current Market Cap: 361.2B INR
For detailed information about LAURUSLABS stock, go to TipRanks’ Stock Analysis page.